Given by Assistant Professor Michael Schatz, Ph.D.
We are in the middle of an incredible transition in biology, driven by the rapidly improved throughput and falling costs of DNA sequencing. These technologies are used, among many other applications, for studying the genetic components of Cancer, Autism and other complex diseases, and to probe the natural world to develop more Robust Crops and Biofuels.
The scope of these projects was almost unthinkable ten years ago. But when it comes to genome sequencing, the future is here as costs continue to plummet and capacity climbs.